Who owns UNITY BIOTECHNOLOGY, INC.?
- Ticker: UBX
- CUSIP Number: 91381u200
Tip: Access positions for across all investors
Analyze quarterly positions in Unity Biotechnology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Unity Biotechnology stock
Who bought or sold UNITY BIOTECHNOLOGY, INC. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Alyeska Investment Group | 2.3M | $4.5M | 76% | Dec 2023 |
|
| Arch Venture Corp | 1.0M | $1.9M | 0% | Dec 2023 |
|
| Vanguard Group | 562k | $1.1M | 0% | Dec 2023 |
|
| Citadel Advisors | 68k | $131k | 27% | Dec 2023 |
|
| Founders Fund V Management | 49k | $95M | 0% | Dec 2023 |
|
| Wells Fargo & Company | 44k | $84k | 0% | Dec 2023 |
|
| Cercano Management | 41k | $80k | 0% | Dec 2023 |
|
| Jane Street | 29k | $55k | 66% | Dec 2023 |
|
| Dimensional Fund Advisors | 26k | $49k | -36% | Dec 2023 |
|
| Commonwealth Equity Services | 24k | $46k | -3% | Dec 2023 |
|
| Laurion Capital Management | 22k | $42k | -69% | Dec 2023 |
|
| Millennium Management | 13k | $26k | 100% | Dec 2023 |
|
| Advisor Group Holdings | 13k | $26k | -43% | Dec 2023 |
|
| Wolverine Trading | 11k | $20k | -39% | Dec 2023 |
|
| UBS Group | 9.3k | $18k | 2483% | Dec 2023 |
|
| Simplex Trading | 2.3k | $4.0k | 100% | Dec 2023 |
|
| Royal Bank of Canada | 461.00 | $1.4k | -76% | Dec 2023 |
|
| Cape Investment Advisory | 300.00 | $579.000000 | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 257.00 | $496.010000 | 2% | Dec 2023 |
|
| Signature | 200.00 | $386.000000 | 0% | Dec 2023 |
|
| Rhumbline Advisers | 129.00 | $248.002500 | 0% | Dec 2023 |
|
| Carmichael Hill & Associates | 100.00 | $193.000000 | 0% | Dec 2023 |
|
| Summit Investment Advisors | 100.00 | $193.000000 | 0% | Dec 2023 |
|
| AllSquare Wealth Management | 55.00 | $106.001500 | 0% | Dec 2023 |
|
| Bank of America Corporation | 8.00 | $15.000000 | 100% | Dec 2023 |
|